Hiccups can have multiple causes, including esophageal lesions. Hiccups after insertion of self-expanding metallic stents have been reported occasionally following stenting for lesions of the gastroesophageal junction. We report a patient who developed hiccups after insertion of a stent for squamous cell carcinoma of the proximal esophagus. The hiccups responded only to the initiation of baclofen therapy.
H iccups or singultus refers to the sound produced by abrupt closure of the glottis after repeated involuntary, spastic contractions of the respiratory muscles. Hiccups are usually self-limited. Th e treatment options for persistent or intractable hiccups are both pharmacological and nonpharmacological. Drugs reported to be useful include baclofen, gabapentin, pregabalin, metoclopramide, domperidone, chlorpromazine, nifedipine, amitriptyline, valproate, carbamazepine, and phenytoin ( 1 ). Nonpharmacologic treatments include hypnosis, acupuncture, nerve stimulation, and nerve blocks for vagus and phrenic nerves ( 1 ) . Hiccups related to placement of self-expanding metallic stent (SEMS) have been reported rarely in the literature ( 2 , 3 ) . We report a case of persistent hiccups following placement of an esophageal stent which responded to baclofen.
CASE REPORT
A 75-year-old man presented with progressively increasing dysphagia to solid foods and weight loss for 3 months. Upper endoscopy showed an ulceroproliferative mass about 20 cm from the incisors, and the endoscope could not be negotiated beyond the lesion. Biopsy revealed squamous cell carcinoma. Chest computed tomography showed asymmetrical mural thickening of the middle esophagus and loss of fat planes, with the aorta and lesion abutting the carina. Using an ultrathin endoscope, the lesion length was assessed and an Ultrafl ex partially covered stent (15 cm) was placed across the lesion for palliation of dysphagia. Th e immediate postendoscopic period was unremarkable. However, 12 hours after stent placement, the patient developed hiccups that did not respond to physical maneuvers, proton pump inhibitors, or chlorpromazine. His metabolic parameters, including liver and kidney function tests, creatinine, and serum electrolytes, were normal. Chest radiographs confi rmed the proper positioning of the stent and the absence of pneumothorax or gas under the diaphragm. Repeat endoscopy showed the stent in place and above the gastroesophageal junction. Th e patient was started on baclofen 5 mg three times daily Baclofen-responsive hiccups after esophageal stenting for malignancy-related dysphagia Vishal Sharma , DM, Arka De , MD, Sandeep Lamoria, MD, and Brinder Mohan Singh Lamba, MD with good clinical response. Baclofen was given for 3 days and then was stopped, with no recurrence of hiccups.
DISCUSSION
Th ere are several known causes of persistent hiccups, including lesions of the refl ex arc, uremia, bronchoscopy, central line placement, and cardiac pacing, as well as gastroesophageal refl ux and esophageal obstruction or distension ( 1, 4 -6 ) . Expansion of SEMS may lead to hiccups by producing esophageal distension, or, in cases in which the gastroesophageal junction is stented, through refl ux or diaphragmatic irritation ( 1 -3 ) . Chlorpromazine is the only agent approved by the US Food and Drug Administration for the treatment of persistent hiccups ( 7 ). Although not approved specifi cally for this indication, baclofen, a centrally acting GABAB agonist, has been found to be eff ective in persistent hiccups and may be considered in patients not responding to chlorpromazine ( 8 , 9 ) . Th is is the fi rst report of a case in which the esophageal stent produced baclofen-responsive hiccups, despite the stent not crossing the gastroesophageal junction. We suggest that stent-related hiccups may be treated with baclofen if they fail to respond to physical maneuvers and chlorpromazine.
